Literature DB >> 11399923

Membranoproliferative glomerulonephritis associated with hypocomplementemic urticarial vasculitis after complete remission of membranous nephropathy.

T Saeki1, M Ueno, H Shimada, S Nishi, N Imai, S Miyamura, F Gejou, M Arakawa.   

Abstract

A 49-year-old-man developed proteinuria in 1978. He was diagnosed as having membranous nephropathy by renal biopsy and was treated with prednisolone. The proteinuria disappeared completely and the treatment was stopped. In 1995, after complete remission, he developed nephrotic syndrome with chronic urticaria and hypocomplementemia. Renal biopsy revealed membranoproliferative glomerulonephritis (type I) and skin biopsy showed leukocytoclastic vasculitis, which was compatible with hypocomplementemic vasculitis syndrome. Steroid therapy was very effective. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11399923     DOI: 10.1159/000045981

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  Hypocomplementemic urticarial vasculitis syndrome: a case report and literature review.

Authors:  Andrew Buck; Jim Christensen; Morgan McCarty
Journal:  J Clin Aesthet Dermatol       Date:  2012-01

2.  Hypocomplementemic urticarial vasculitis syndrome with gastrointestinal vasculitis and crescentic membranoproliferative glomerulonephritis without immune complex deposits.

Authors:  Kenji Ueki; Akihiro Tsuchimoto; Yuta Matsukuma; Kumiko Torisu; Kiichiro Fujisaki; Takehiro Torisu; Yuichi Yamada; Yoshinao Oda; Kosuke Masutani; Toshiaki Nakano; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  CEN Case Rep       Date:  2019-10-04

3.  Biopsy-proven kidney involvement in hypocomplementemic urticarial vasculitis.

Authors:  Alice Corthier; Marie Jachiet; Daniel Bertin; Aude Servais; Christelle Barbet; Adrien Bigot; Marie-Sylvie Doutre; Didier Bessis; Ancuta Bouffandeau; Olivier Moranne; Pierre-André Jarrot; Nathalie Bardin; Benjamin Terrier; Stephane Burtey; Xavier Puéchal; Laurent Daniel; Noémie Jourde-Chiche
Journal:  BMC Nephrol       Date:  2022-02-16       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.